Basal local cerebral glucose utilization is not altered after behavioral sensitization to quinpirole

Neuroscience Letters

Volumn 429, Issue 2-3, 2007, Pages 165-168

  Richards, Toni L ^a   Pazdernik, Thomas L ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

14C 2 deoxyglucose; Local cerebral glucose utilization; Psychostimulant; Quinpirole; Sensitization

Indexed keywords

DEOXYGLUCOSE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PSYCHOSTIMULANT AGENT; QUINPIROLE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CELL POPULATION; CONTROLLED STUDY; CORPUS STRIATUM; GLUCOSE BRAIN LEVEL; GLUCOSE UTILIZATION; LIMBIC CORTEX; LOCOMOTION; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; DEOXYGLUCOSE; DOPAMINE; DOPAMINE AGONISTS; ENERGY METABOLISM; GLUCOSE; MALE; MOTOR ACTIVITY; NEURONS; QUINPIROLE; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D2; SENSITIVITY AND SPECIFICITY;

EID: 36348946815     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.10.006     Document Type: Article

References (37)

1. 14C-2-deoxyglucose autoradiography. J. Neurosci. 8 (1988) 1951-1961
2. Carpenter T.L., Pazdernik T.L., and Levant B. Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats. Brain Res. 964 (2003) 295-301
3. Clow D.W., and Hammer J.R.P. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions. Bromocriptine enhances recovery. Neuropsychopharmacology 4 (1991) 71-75
4. Culver K.E., and Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur. J. Pharmacol. 339 (1997) 109-111
5. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
6. 2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161 (1989) 151-157
7. Einat H., and Szechtman H. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behav. Brain Res. 54 (1993) 35-41
8. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Brain Res. Rev. 19 (1994) 223-239
9. Jackson D.M., Bailey R.C., Christie M.J., Crisp C.A., and Skerritt J.H. Long-term d-amphetamine in rats: lack of change in post-synaptic dopamine receptor sensitivity. Psychopharmacology (Berl.) 73 (1981) 276-280
10. Jaffe J.H. Drug addiction and drug abuse. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). The Pharmacological Basis of Therapeutics (1993), McGraw-Hill, New York 522-573
11. Kolta M.G., Shreve P., and De Souza N.J.V. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24 (1985) 823-829
12. Kuczenski R., and Leith N.J. Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?. Pharmacol. Biochem. Behav. 15 (1981) 405-413
13. Leith N.J., and Kuczenski R. Chronic amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the drug. Pharmacol. Biochem. Behav. 15 (1981) 399-404
14. 2-like dopamine receptors in rat brain. J. Pharmacol. Exp. Ther. 262 (1992) 929-935
15. Lynch M., Kenny M., and Leonard B.E. The effect of chronic administration of C-amphetamine on regional changes in catecholamines in the rat brain. J. Neurosci. Res. 3 (1977) 295-300
16. Mittleman G., Castaneda E., Robinson T.E., and Valenstein E.S. The propensity for nonregulatory ingestive behavior is related to differences in dopamine systems: behavioral and biochemical evidence. Behav. Neurosci. 100 (1986) 213-220
17. Nishikawa T., Mataga N., Takashima M., and Toru M. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88 (1983) 195-203
18. Orzi F., Dow-Edwards D., Jehle J., Kennedy C., and Sokoloff L. Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat. J. Cereb. Blood Flow Metab. 3 (1983) 154-160
19. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25 (1997) 192-216
20. Post R.M., and Contel N.R. Cocaine-induced behavioral sensitization: a model for recurrent manic illness. In: Perris C., Struwe G., and Jansson B. (Eds). Biological Psychiatry (1981), Elsevier, Amsterdam 746-749
21. Richards T.L., Pazdernik T.L., and Levant B. Altered quinpirole-induced local cerebral glucose utilization in anterior cortical regions in rats after sensitization to quinpirole. Brain Res. 1042 (2005) 53-61
22. Richards T.L., Pazdernik T.L., and Levant B. Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilization. Brain Res. 1160 (2007) 124-133
23. Robinson T.E., and Becker J.B. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85 (1982) 253-254
24. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396 (1986) 157-198
25. Robinson T.E., and Becker J.B. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res. 253 (1982) 231-241
26. Robinson T.E., Becker J.B., Moore C.J., Castaneda E., and Mittleman G. Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res. 343 (1985) 374-377
27. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
28. Schmidt W.J., and Beninger R.J. Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia. Neurotoxic. Res. 10 (2006) 161-166
29. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28 (1977) 897-916
30. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res. 41 (2003) 203-228
31. Szechtman H., Sulis W., and Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav. Neurosci. 112 (1998) 1475-1485
32. Tsai S.J., Huang Y.H., Chang L.S., Yang Y.C., and Sim C.B. Alterations in local cerebral glucose utilization in rats after chronic amphetamine administration without subsequent challenge. Psychiatry Res. 57 (1995) 63-73
33. Tsuruta K., Frey E.A., Grewe C.W., Cote T.E., Eskay R.L., and Kebabian J.W. Evidence that LY-141865 specifically stimulates the D2 dopamine receptor. Nature 292 (1981) 463-465
34. Van Hartesveldt C. Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats. Pharmacol. Biochem. Behav. 58 (1987) 955-960
35. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.) 151 (2000) 99-120
36. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci. Biobehav. Rev. 27 (2004) 827-839
37. Wolf M.E. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol. Interv. 2 (2002) 146-157